Anticoagulation Therapy In Risky Geriatric Cardiac Patients

Anticoagulation Therapy In Risky Geriatric Cardiac Patients In the realm of cardiovascular health, the coexistence of atrial fibrillation (AF) with heart failure (HF) presents a significant challenge for anticoagulation, particularly in the aging population. Uncertainties abound regarding treatment efficacy and patient outcomes. The All Nippon AF In the Elderly (ANAFIE) Registry,

Anticoagulation Therapy In Risky Geriatric Cardiac Patients